In all cases, the tumor cells were immunoreactive for CD34, desmin, smooth muscle actin (SMA), and estrogen receptor (ER) and negative for cytokeratin, p63, CD68, and beta-catenin (Figures 3B-3D). This evidence concerns the gene SMN1 and neoplasm.